BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has received 510(k) clearance from the U.S. Food and Drug ...

BOULDER, Colo.--(BUSINESS WIRE)--Expanding its industry-leading vessel and tissue sealing portfolio, Covidien (NYSE:COV) received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ...

Covidien ($COV) won U.S. FDA 510(k) clearance for a combination laparoscopic surgical device. Known as the LigaSure laparoscopic sealer and divider, the device makes ...

Covidien recently announced that the FDA has cleared its next generation LigaSure surgical tool. The company announced the 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic ...

The LigaSure Impact device promises an advanced surgical experience with improved visibility, more intuitive jaw positioning and enhanced ergonomics. On the other hand, the LigaSure blunt tip ...

Medtronic has secured EU CE mark approval for LigaSure RAS, a vessel-sealing instrument for use with the company’s Hugo robotic-assisted surgery (RAS) system. LigaSure is indicated for sealing and ...

Global medical device corporations Medtronic said on the 5th it will launch in Korea the surgical energy instrument "LigaSure™," which can be mounted on and used with its robotic surgery system "Hugo™ ...

The jury in Santa Ana found Medtronic violated antitrust law by selling ‌its LigaSure device below cost and bundling it with other products, according to an attorney for Applied Medical, which sells a ...

Medtronic has developed a portfolio of blood vessel sealing devices known as the LigaSure. By Reducing the cost of purchasing and manufacturing the device, Team 7 has designed the next step in ...